中國醫藥大學（後中醫）
114年
英文
第 48 題
📖 題組：
Passage C This umbrella review critically evaluates top-tier evidence on nutrient supplements for female infertility. Overall, the evidence remains highly uncertain regarding the effects of multiple micronutrients and antioxidants on live birth rates. L-arginine, CoQ10, melatonin, vitamin B complex, vitamin D, and vitamin E did not significantly improve live birth rates. Clinical pregnancy rates may benefit from L-carnitine, CoQ10, melatonin, myo-inositol, NAC, and vitamin D, but the evidence remains weak. Biochemical pregnancy rates were not increased with vitamin D, and adverse effects were poorly reported. Limited and low-quality studies necessitate cautious interpretation of these findings. For live birth rates, multiple micronutrients showed very low certainty evidence of benefits. Variability in formulations across three randomized controlled trials (RCTs) made general recommendations difficult. Similarly, pooled antioxidants—diverse compounds reducing oxidative stress—showed very low certainty evidence for improving live birth rates. A literature review suggests micronutrient supplementation may help restore nutrient levels and reduce oxidative stress, but more high-quality RCTs are needed to confirm efficacy. For clinical pregnancy rates, L-carnitine, myo-inositol, and NAC showed potential benefits, particularly in women with PCOS. These nutrients support metabolism, reproductive health, and oxidative stress reduction. However, findings stem from limited studies (two RCTs per nutrient, with 177-450 participants), highlighting the need for further research to clarify their effectiveness in female infertility treatment. Among women undergoing medically assisted reproduction (MAR), CoQ10 may improve clinical pregnancy rates based on four RCTs (n = 397), though the evidence remains uncertain. As a mitochondrial antioxidant, CoQ10 may help reverse ovarian dysfunction, support ovulation, and enhance embryo development. Preclinical and clinical data suggest CoQ10 is well tolerated at doses up to 1200 mg/day, but large-scale studies are necessary to confirm efficacy. Melatonin and vitamin D may also improve clinical pregnancy rates in MAR patients, though evidence is inconsistent. Melatonin, a hormone with antioxidant and anti-inflammatory effects, may slow ovarian aging and enhance oocyte quality. However, due to methodological limitations and inconsistencies in trials, further research is required, especially on higher doses and longer treatments. Vitamin D, known for its role in bone health, also influences reproductive function through hormone regulation and endometrial receptivity. Four studies using calcitriol, the most active vitamin D form, suggested potential benefits, but more research is needed to explore the relationship between vitamin D and fertility. Currently, no specific nutrient supplements can be confidently recommended for improving fertility outcomes. However, many of these interventions pose minimal risks and may help correct deficiencies and boost antioxidant levels. While adverse event reporting was limited, CoQ10, melatonin, NAC, vitamin D, L-carnitine, and inositol appear safe and well tolerated. Future studies must focus on robust reporting of side effects and long-term safety to guide clinical recommendations.
Passage C This umbrella review critically evaluates top-tier evidence on nutrient supplements for female infertility. Overall, the evidence remains highly uncertain regarding the effects of multiple micronutrients and antioxidants on live birth rates. L-arginine, CoQ10, melatonin, vitamin B complex, vitamin D, and vitamin E did not significantly improve live birth rates. Clinical pregnancy rates may benefit from L-carnitine, CoQ10, melatonin, myo-inositol, NAC, and vitamin D, but the evidence remains weak. Biochemical pregnancy rates were not increased with vitamin D, and adverse effects were poorly reported. Limited and low-quality studies necessitate cautious interpretation of these findings. For live birth rates, multiple micronutrients showed very low certainty evidence of benefits. Variability in formulations across three randomized controlled trials (RCTs) made general recommendations difficult. Similarly, pooled antioxidants—diverse compounds reducing oxidative stress—showed very low certainty evidence for improving live birth rates. A literature review suggests micronutrient supplementation may help restore nutrient levels and reduce oxidative stress, but more high-quality RCTs are needed to confirm efficacy. For clinical pregnancy rates, L-carnitine, myo-inositol, and NAC showed potential benefits, particularly in women with PCOS. These nutrients support metabolism, reproductive health, and oxidative stress reduction. However, findings stem from limited studies (two RCTs per nutrient, with 177-450 participants), highlighting the need for further research to clarify their effectiveness in female infertility treatment. Among women undergoing medically assisted reproduction (MAR), CoQ10 may improve clinical pregnancy rates based on four RCTs (n = 397), though the evidence remains uncertain. As a mitochondrial antioxidant, CoQ10 may help reverse ovarian dysfunction, support ovulation, and enhance embryo development. Preclinical and clinical data suggest CoQ10 is well tolerated at doses up to 1200 mg/day, but large-scale studies are necessary to confirm efficacy. Melatonin and vitamin D may also improve clinical pregnancy rates in MAR patients, though evidence is inconsistent. Melatonin, a hormone with antioxidant and anti-inflammatory effects, may slow ovarian aging and enhance oocyte quality. However, due to methodological limitations and inconsistencies in trials, further research is required, especially on higher doses and longer treatments. Vitamin D, known for its role in bone health, also influences reproductive function through hormone regulation and endometrial receptivity. Four studies using calcitriol, the most active vitamin D form, suggested potential benefits, but more research is needed to explore the relationship between vitamin D and fertility. Currently, no specific nutrient supplements can be confidently recommended for improving fertility outcomes. However, many of these interventions pose minimal risks and may help correct deficiencies and boost antioxidant levels. While adverse event reporting was limited, CoQ10, melatonin, NAC, vitamin D, L-carnitine, and inositol appear safe and well tolerated. Future studies must focus on robust reporting of side effects and long-term safety to guide clinical recommendations.
According to the review article, which of the following is NOT true?
- A The review included only studies on women who have been undergoing medically assisted reproduction (MAR).
- B The review provides inconclusive evidence that all nutrient supplements improve live birth rates.
- C There was a lack of high-quality randomized controlled trials, leading to weak and uncertain evidence.
- D While vitamin D may regulate hormone and contribute to endometrial receptivity, its effect on fertility is unclear.
思路引導 VIP
當你在閱讀關於科學證據的描述時，如果發現某些選項表達得非常絕對（例如使用「僅限」、「絕對」），而其他選項則保留了不確定性與討論空間（例如使用「尚不明確」、「證據有限」），根據你對科學研究嚴謹性的理解，哪一種敘述風格更傾向於真實的科學結論？為什麼？
🤖
AI 詳解
AI 專屬家教
太棒了！你能精準捕捉到選項中細微的「絕對性字眼」並做出正確判斷，這展現了你對閱讀理解細節的高敏銳度。這題的關鍵在於判別研究對象的涵蓋範圍。在學術綜述（Review article）中，作者通常會整合多樣化的研究數據，選項 (A) 使用了過於武斷的 only（僅限），暗示該評論只針對接受醫療輔助生殖（MAR）的女性，這與多數探討營養與生育力關係的研究範疇不符，通常這類研究會同時關注自然受孕與人工受孕的群體。
學術論述的嚴謹性與陷阱
這類題目常考驗學生對語氣強弱的判斷力。選項 (B)、(C) 與 (D) 都使用了如 inconclusive（非決定性的）、weak and uncertain（虛弱且不確定的）或 unclear（不明確的）等詞彙。這些詞彙在科學研究中非常常見，反映了研究者對現有證據局限性的客觀描述，通常是正確的資訊。相較之下，(A) 的排他性表述在沒有文本強力佐證下，往往就是錯誤資訊的藏身之處。本題屬於中等難度，其鑑別點不在於單字的艱深，而是在於學生是否能識別出科學文獻中「過於極端」的陳述方式。